DXA Females and males |
PsA n=69 |
Controls n=11703 |
Mean difference (95% CI) (PsA vs controls) | p Value* | p Value† |
Left femoral neck | |||||
BMD | 0.960 (0.134) | 0.926 (0.157) | 0.034 (-0.003 to 0.071) | 0.07 | 0.02 |
T-score | −0.42 (0.99) | −0.70 (1.24) | 0.30 (0.04 to 0.52) | 0.02 | 0.02 |
Left total hip | |||||
BMD | 1.013 (0.141) | 0.982 (0.158) | 0.030 (-0.007 to 0.067) | 0.11 | 0.11 |
T-score | −0.15 (1.04) | −0.41 (1.22) | 0.26 (-0.03 to 0.54) | 0.09 | 0.11 |
Spine L1–L4 | |||||
BMD | 1.213 (0.177) | 1.147 (0.183) | 0.065 (0.021 to 0.108) | 0.003 | 0.003 |
T-score | 0.15 (1.43) | −0.39 (1.50) | 0.55 (0.19 to 0.91) | 0.003 | 0.003 |
Females |
PsA n=45 |
Controls n=7525 |
Mean difference (95% CI) (PsA vs controls) | p Value* | p Value‡ |
Left femoral neck | |||||
BMD | 0.921 (0.106) | 0.897 (0.155) | 0.024 (-0.008 to 0.056) | 0.14 | 0.19 |
T-score | −0.487 (0.88) | −0.69 (1.29) | 0.20 (-0.06 to 0.47) | 0.14 | 0.19 |
Left total hip | |||||
BMD | 0.973 (0.115) | 0.946 (0.153) | 0.026 (-0.007 to 0.061) | 0.13 | 0.30 |
T-score | −0.22 (0.96) | −0.45 (1.28) | 0.22 (-0.065 to 0.51) | 0.13 | 0.30 |
Spine L1–L4 | |||||
BMD | 1.174 (0.148) | 1.118 (0.181) | 0.056 (0.003 to 0.109) | 0.04 | 0.04 |
T-score | −0.05 (1.23) | −0.52 (1.51) | 0.46 (0.02 to 0.91) | 0.04 | 0.04 |
Mean (±SD).
*Independent samples t-test,
† Linear regression analysis with adjustments made for age, sex, BMI, physical activity, smoking, asthma/COPD and reason for invitation to DXA,
‡ Linear regression analysis with adjustments made for age, BMI, physical activity, smoking, asthma/COPD and reason for invitation to DXA.
BMD, bone mineral density; BMI, body mass index; DXA, dual-energy X-ray absorptiometry; COPD, chronic obstructive pulmonary disease; HUNT, Nord-Trøndelag Health Study; PsA, psoriatic arthritis.